Gee. I wonder what they could have used the money for, other than developing other formulations of the drug like time-release for UC; getting more Brilacidin manufactured to use in clinical trials; paying for those clinical trials; paying other fees and (who knows?) maybe consultants to help with applications; setting up clinical trials in other countries; and so many other things we may not know about.

None of the MANY activities the company has engaged in are free. It's remarkable that the company has made so much progress for so little money in the past year.